PSMA-targeted radioligand therapies for prostate cancer.
Founders
David Gauden(United Kingdom · ♂)— A radiopharmaceuticals veteran who co-founded Blue Earth Diagnostics, he led the 2021 spin-out of Blue Earth Therapeutics from Bracco to develop next-generation cancer radiotherapeutics.
Members see the full profile
Create a free EquityFlow account to see Blue Earth Therapeutics's 1 funding round, 2 investors, 12 similar companies.